[Federal Register Volume 76, Number 40 (Tuesday, March 1, 2011)]
[Notices]
[Pages 11252-11253]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-4544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
USC, as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group; Training and Career Development Subcommittee.
    Date: March 9-10, 2011.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Eliane Lazar-Wesley, Ph.D., Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-451-4530, <a href="/cdn-cgi/l/email-protection#7411184206341a1d1c5a131b02"><span class="__cf_email__" data-cfemail="2d48411b5f6d434445034a425b">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA-K Conflicts.
    Date: March 9, 2011.
    Time: 5 p.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-402-6626, <a href="/cdn-cgi/l/email-protection#1a7d77762e2f7b5a747372347d756c"><span class="__cf_email__" data-cfemail="a0c7cdcc9495c1e0cec9c88ec7cfd6">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Pharmacological Development of Treatment Agents and 
Formulations or Tobacco Dependence.
    Date: March 18, 2011.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, <a href="/cdn-cgi/l/email-protection#bdcfc8d4c7d7dbfdd3d4d9dc93d3d4d593dad2cb"><span class="__cf_email__" data-cfemail="5321263a293935133d3a37327d3d3a3b7d343c25">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; High Throughput Screening for Nicotinic Receptor 
Subunits.
    Date: March 24, 2011.
    Time: 2:30 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-402-6626, <a href="/cdn-cgi/l/email-protection#a8cfc5999c9dc9e8c6c1c086cfc7de"><span class="__cf_email__" data-cfemail="88efe5b9bcbde9c8e6e1e0a6efe7fe">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Training in Computational Neuroscience (T90/R90).
    Date: March 30, 2011.
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Minna Liang, Ph.D., Scientific Review Officer, 
Grants Review Branch, Office of Extramural Affairs, National 
Institute on Drug Abuse, NIH, Room 4226, MSC 9550, 6001 Executive 
Blvd.,

[[Page 11253]]

Bethesda, MD 20892-9550, 301-435-1432, <a href="/cdn-cgi/l/email-protection#14787d757a7379547a7d70753a7a7d7c3a737b62"><span class="__cf_email__" data-cfemail="3f53565e5158527f51565b5e1151565711585049">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Training in Neuroimaging (T90) (RFA DA11-006).
    Date: March 31, 2011.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Scott A Chen, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4234, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-443-9511, <a href="/cdn-cgi/l/email-protection#a3c0cbc6cdd0c0e3cec2cacf8dcdcacb8dc4ccd5"><span class="__cf_email__" data-cfemail="cba8a3aea5b8a88ba6aaa2a7e5a5a2a3e5aca4bd">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: February 23, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-4544 Filed 2-28-11; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>